Coty Inc. — Form 10-Q Summary
Reporting period: Fiscal first quarter ended September 30, 2015; compared with the three months ended September 30, 2014. Coty manufactures and markets fragrances, color cosmetics, and skin and body care products globally. The filing is unaudited. Coty notes that its business is seasonal, with stronger holiday-related demand typically in the second fiscal quarter.
Key financial results
| Metric | Q1 FY2016 | Q1 FY2015 |
|---|---|---|
| Net revenue | $1,112.3 million | $1,182.3 million |
| Gross profit / margin | $668.6 million / 60.1% | $700.1 million / 59.2% |
| Operating income / margin | $81.7 million / 7.3% | $120.1 million / 10.2% |
| Adjusted operating income / margin (non-GAAP) | $173.4 million / 15.6% | $167.1 million / 14.1% |
| Net income attributable to Coty | $125.7 million | $10.6 million |
| Diluted EPS attributable to Coty | $0.34 | $0.03 |
| Adjusted net income attributable to Coty (non-GAAP) | $219.7 million | $103.0 million |
| Cash from operating activities | $116.7 million | $26.2 million |
| Cash and cash equivalents at period end | $416.0 million | $1,002.7 million |
| Total debt at period end | $2,792.5 million | $2,634.7 million at June 30, 2015 |
Material changes and operating trends
- Revenue fell 6% year over year. Coty attributed the decline primarily to a 9% adverse foreign-exchange translation effect, partly offset by 8% higher unit volume; price and mix reduced revenue by 5%. Excluding currency, Bourjois, and the TJoy/China Optimization effects, revenue declined 2%.
- Fragrances revenue declined 14% and Skin & Body Care declined 12%; Color Cosmetics revenue rose 14%, including a 14% contribution to segment revenue from Bourjois. Currency was a significant headwind across regions.
- Gross margin improved about 90 basis points, reflecting lower cost of sales; management attributed roughly 70 basis points of improvement, excluding specified acquisition-related and prior-year items, primarily to supply-chain savings.
- GAAP operating income declined 32%, while adjusted operating income increased 4% (12% excluding currency). The gap chiefly reflects higher restructuring and acquisition-related costs and a $5.5 million impairment charge.
- Net income increased substantially, but comparisons are distorted by a $193.9 million IRS settlement tax benefit in the current quarter and an $88.8 million loss on early debt extinguishment in the prior-year quarter. The tax benefit included $164.2 million primarily from recognition of deferred tax assets; $113.0 million was offset by a valuation allowance.
- Operating cash flow rose to $116.7 million, which management attributed mainly to the timing of receivable collections and working-capital needs. Investing used $42.5 million, principally capital expenditures; financing provided $6.6 million, including borrowing activity and partly offset by $155.7 million of share repurchases.
Liquidity, debt, and capital allocation
- At September 30, 2015, total debt was $2,792.5 million, including $293.5 million drawn on the revolving facility, versus total debt of $2,634.7 million at June 30. Long-term debt was $2,750.6 million. Coty reported compliance with its credit-agreement financial covenants.
- Management said cash, operating cash generation, and access to revolving and other credit facilities were expected to provide sufficient near- and long-term liquidity. Cash flows are seasonal.
- The board authorized up to $700 million of Class A share repurchases. Coty repurchased 5.5 million shares for $155.7 million in the quarter; the filing reported approximately $544.3 million remaining under the program at September 30. Coty also declared a $0.25-per-share dividend.
Outlook, transactions, risks, and unusual items
- The filing provides no specific earnings or revenue guidance. Management described a challenging market, particularly mass fragrance in Western Europe and the U.S.; it emphasized growth of its power brands, innovation, execution, and geographic and channel expansion, while expecting gradual declines in non-power brands later in their life cycles.
- Restructuring costs were $62.1 million in the quarter. The Bourjois Acquisition Integration Program is expected to generate approximately $67 million of total pre-tax restructuring and related costs, all cash costs, with substantial completion expected by fiscal 2017. Organizational Redesign costs are estimated at $145 million to $180 million in total, with substantial completion expected by fiscal 2017.
- The proposed P&G Specialty Beauty Business Reverse Morris Trust transaction was estimated at approximately $13.0 billion as of September 30, including approximately 413 million shares intended to give P&G shareholders 52% of the combined company on a fully diluted basis and assumption of $1.9 billion of debt. Closing was expected in the second half of calendar 2016, subject to approvals and other conditions; final value depends on closing-date factors.
- Subsequent events: Coty entered a new $4.5 billion senior secured credit agreement on October 27, 2015, refinancing existing facilities. On November 2, it agreed to acquire Hypermarcas’ Brazilian beauty and personal care business for approximately $1.0 billion cash, with staged closing expected by March 2016. These events occurred after the reporting date.
- Coty recorded a $5.5 million impairment of customer relationships following a Southeast Asia go-to-market review. The company also faces a pending IPO-related securities class action and a U.S. antiboycott compliance review concerning UAE subsidiary export documentation. Coty said a material penalty from the latter was reasonably possible, but had not established a reserve and could not estimate any penalty.
- Other risks identified include foreign-exchange and international-market exposure, consumer and retail trends, product-launch execution, acquisition integration and financing, restructuring execution, and seasonal working-capital needs. Coty stated that disclosure controls were effective at the reasonable-assurance level and that no material internal-control changes were identified.
Important facts for investors to verify
- Underlying revenue and segment trends after separating currency, Bourjois, and other portfolio effects, particularly continued weakness in Fragrances and Skin & Body Care.
- The extent to which adjusted operating improvement reflects sustainable cost savings versus excluded restructuring and acquisition-related charges; review the company’s non-GAAP reconciliations.
- The durability and cash-tax implications of the IRS settlement benefit, including deferred tax assets and valuation allowances.
- Debt, covenant headroom, and financing needs after the new credit facilities and the proposed P&G and Hypermarcas transactions.
- Cash costs and completion progress for restructuring, the share-repurchase program, and the dividend relative to seasonal working-capital requirements.
- Closing conditions, final consideration and dilution for the P&G transaction; funding, integration, and closing conditions for Hypermarcas; and developments in the antiboycott review and litigation.